Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_F88116DF20BF
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.
Journal
European journal of cancer
Author(s)
Margalit O., Harmsen W.S., Shacham-Shmueli E., Voss M.M., Boursi B., Wagner A.D., Cohen R., Olswold C.L., Saltz L.B., Goldstein D.A., Hurwitz H., Tebbutt N.C., Kabbinavar F.F., Adams R.A., Chibaudel B., Grothey A., Yoshino T., Zalcberg J., de Gramont A., Shi Q., Lenz H.J.
ISSN
1879-0852 (Electronic)
ISSN-L
0959-8049
Publication state
Published
Issued date
11/2023
Peer-reviewed
Oui
Volume
194
Pages
113339
Language
english
Notes
Publication types: Published Erratum
Publication Status: ppublish
OAI-PMH
oai:serval.unil.ch:BIB_F88116DF20BF
DOI
10.1016/j.ejca.2023.113339
Pubmed
37813779
Create date
13/10/2023 9:45
Last modification date
05/12/2023 8:05
Usage data